Gelteq Ltd (GELS)

• Market cap: $11.1M
• 1 day: -8.77%
• 5 days: 10.63%
• 1 month: 156.79%
• 3 months: 42.27%
• 6 months: 20.94%
• Year to date: 24.15%
• 1 year: -42.54%
• 5 years: -64.63%
• 10 years: -64.63%
• Sector: Healthcare
• Industry: Drug Manufacturers - Specialty & Generic

About: Gelteq Ltd is a clinical and science-based company focused on developing and commercializing white label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care and other products, preserving the simplicity, accessibility, and efficacy of oral delivery. Its principal products are edible gels and their application in gel-based dosage forms across pets, sports, pharmaceutical, over-the-counter, and nutraceutical categories, leveraging its patent pending multiple ingredient dosage forms. The company develops and tests gel-based delivery systems for humans and pets and focuses on out-licensing its technology to companies to create products that can be manufactured and sold, while continuing to manufacture existing products under license on a white label basis.

Employees: 8